2-Propenoic acid, 3-[2-[3-[(bromoacetyl)oxy]butyl]-1,3-dithian-2-yl]-,2-[(4-methylphenyl)sulfonyl]ethyl ester, (E)-
CAS No. 38634-39-8
Pembrolizumab 1426814-54-1